zadnja posodobitev :
19/11/2024
Vazodilatator   Papaverine hydrochloride  
Brizgalka
Stabilnost raztopine Stabilnost mešanice Faktorji, ki vplivajo na stabilnost Kompatibilnost način aplikacije Viri pdf
   Kemična formula  

Lastniško ime   Lastniško ime     

Sestava pomožnih snovi je med paralelami lahko različna

DBL papaverine hydrochloride nova Zelandija
Papaverin Recip Švedska
Papaverine chlorhydrate Francija, Malezija
Viri   Brizgalka   Viri : Papaverine hydrochloride  
Tip objava
456 časopis Tu YH, Allen LV, Wang DP.
Stability of papaverine hydrochloride and phentolamine mesylate in injectable mixtures.
Am J Hosp Pharm 1987 ; 44: 2524-2527.
939 časopis Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1085 časopis Irving HD, Burbridge BE.
Incompatibility of contrast agents with intravascular medications.
Radiology 1989 ; 173: 91-92.
1899 časopis Trissel LA, Zhang Y.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Int J Pharm Compound 2004 ; 8, 3: 231-235.
2150 časopis Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
J Urology 1998 ; 160; 2: 551-555.
3448 časopis Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Ann Pharm Fr 2013 ; 71, 5: 358-363.

  Mentions Légales